Navigation Links
New Details Presented at the World Parkinson Congress on Neurologix's Successful Phase 2 Trial of Gene Therapy for Parkinson's Disease
Date:10/1/2010

between the treated and sham groups on the UPDRS Part 3 (Motor section), which has long been the standard for clinical assessment in Parkinson's disease.  All subjects were evaluated at baseline as well as at one, three and six months after undergoing surgery.

The trial also showed that NLX-P101 was well-tolerated with no serious adverse events related to the drug or procedure reported.  All treated subjects will continue to be monitored for safety for a 12-month period following their surgical procedure.

About Parkinson's Disease

Parkinson's disease is a progressive and debilitating neurodegenerative disorder that arises from the gradual deterioration of nerve cells in the brain.  It affects the control of bodily movement and is characterized by four principal symptoms: limb tremor, limb rigidity, bradykinesia (slowness of movement) and postural instability (trouble with balance).  Parkinson's disease is a disease of late middle age, usually affecting people over the age of 50.  According to the National Parkinson Foundation, one million Americans currently have PD, and an estimated 50,000 to 60,000 new cases are diagnosed each year in the United States.  Standard therapy for PD often involves use of levodopa, a drug which stimulates production of dopamine.  Unfortunately, many patients develop complications from dopaminergic interventions.  Alternative treatments include deep brain stimulation, which requires general anesthesia and the implantation of permanent medical devices in the brain.

About Neurologix

Neurologix, Inc., (OTC Bulletin Board: NRGX) is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of gene transfer therapies for serious disorders of the brain and CNS.  Neurologix's therapeutic approach is built upon the groundbreakin
'/>"/>

SOURCE Neurologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. PulmoBioTech Announces Details of Its Regulatory Approval Experiments
2. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
3. Newly Published Article Details How PGS Techniques Directly Effect Successful Pregnancy Outcomes
4. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
5. Young Innovations, Inc. Provides Third Quarter Conference Call Details
6. Cord Blood America Details Las Vegas Laboratory Progress in Analyst Interview
7. Young Innovations, Inc. Provides 4th Quarter Conference Call Details
8. Kendle Announces Details Regarding Second Quarter 2010 Earnings Conference Call and Webcast
9. Young Innovations, Inc. Provides 2nd Quarter Conference Call Details
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013  Healthcare providers are ... content management (ECM) solution, for a ... System .  These organizations identified enterprise content ... will use OnBase to optimize their Meditech ... (Logo:  http://photos.prnewswire.com/prnh/20090130/65710LOGO  ) ...
(Date:5/22/2013)... , May 22, 2013 STEPh, Inc., a ... the launch of their web site ( http://www.stephreports.com ... About STEPh Reports STEPh ... Each STEPh Report assesses the competitive ... projected launch year, company, and specific key issues.  STEPh ...
(Date:5/22/2013)... 22, 2013   Life Line Screening  (LLS), ... today the creation of a unique partnership with ... MCM is a population health management organization. LLS ... of clients. These important expanded services will help MCM ... Effective prevention reduces cost of care when individuals are ...
Breaking Medicine Technology:Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2
(Date:5/22/2013)... -- Fish oil supplements could help reduce the ... The supplements, also known as omega-3 ... adiponectin that,s linked to insulin sensitivity, Harvard researchers ... bloodstream have also been linked to a lower ... studies found fish oil increased circulating adiponectin, whether ...
(Date:5/22/2013)... A 2012 survey of internal medicine residents at Massachusetts ... teaching hospitals found that more than half rated ... substance use disorders as fair or poor. Significant numbers ... similar to surveys of practicing physicians. In response to ... Substance Abuse , the MGH has increased residents, training ...
(Date:5/22/2013)... depression have on his young son or daughter? When fathers ... their children benefit, said a University of Illinois study. , ... to be able to attend to the child,s emotional state, ... notice whether he is getting frustrated or needs help. Depressed ... U of I professor of human development. , But if ...
(Date:5/22/2013)... IL A new study suggests that disturbed ... of depression and greater uncertainly about future success. ... and teachers appears to have a protective effect. ... significantly associated with depressed mood and greater uncertainty ... from parents and from teachers were associated with ...
(Date:5/22/2013)... to the "power plants" that make energy to keep ... preventing emergence of the drug-resistant forms of cancer ... That,s the conclusion of a new study published in ... Shana Kelley and colleagues explain that doxorubicin and other ... inside the nucleus of cancer cells. Cancer cells divide ...
Breaking Medicine News(10 mins):Health News:Fish Oil Pills Might Cut Diabetes Risk, Researchers Say 2Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4Health News:Good marriage can buffer effects of dad's depression on young children 2Health News:Parent and teacher support protects teens from sleep problems and depression 2
... of Psychiatry at Case Western Reserve University School of Medicine ... Institute of Mental Health (NIMH) for the long-term study of ... NIMH, one of the National Institutes of Health (NIH), funds ... which 707 children between the ages of six and 12 ...
... By Maryann Mott HealthDay Reporter , THURSDAY, ... twice before snuggling in bed at night with Fido or ... issue of the public health journal Emerging Infectious Diseases ... that cause mild to life-threatening illness in people. Of ...
... HealthDay Reporter , THURSDAY, Jan. 20 (HealthDay ... greatly increases the chances of dying, new research ... analysis, of previously published studies that looked at ... Six of seven studies found pre-existing diabetes was ...
... (HealthDay News) -- Many young American couples can,t agree on ... a new study shows. Oregon State University researchers analyzed ... 18 to 25. In 40 percent of those couples, one ... the other partner said there was no such deal. ...
... paper published Jan. 21 in the journal Science , ... Blossom Damania, PhD, has shown for the first time that ... a key molecule involved in the human immune response. ... Kenan, Jr. Distinguished Professor, Jenny Ting, PhD. First ...
... Ky. Healthcare workers can most directly affect quality of ... helping manage symptoms such as pain, lack of energy, shortness ... a study recently published in the journal Oncology Nursing ... or the degree to which a symptom bothers a person, ...
Cached Medicine News:Health News:Case Western Reserve receives $7.8M to study manic symptoms in children 2Health News:Case Western Reserve receives $7.8M to study manic symptoms in children 3Health News:Pets May Pass Illnesses to Owners 2Health News:Pets May Pass Illnesses to Owners 3Health News:Breast Cancer Patients With Diabetes May Fare Worse 2Health News:Breast Cancer Patients With Diabetes May Fare Worse 3Health News:Young Couples Often Disagree About Monogamy, Study Finds 2Health News:Viral protein mimic keeps immune system quiet 2Health News:Controlling symptoms can lead to improved quality of life for end-of-life patients 2
... the highest g-force ever. But optimal productivity ... Optima MAX combines maximum force, capacity, and ... that's worlds apart from any other system. ... enhanced efficiency, Optima takes productivity to the ...
... generating 694,000 x g at ... Beckman Coulter's Optima L-90K Ultracentrifuge ... separations in less time. This ... a broad range of superb ...
... With the ability to provide a simple, ... in lipemic samples), the Airfuge CLS delivers ... can be cleaned in 10 minutes, eliminating ... tabletop centrifuge: Reaches top speed in as ...
The Dimension RxL Max is an integrated chemistry system and is the most powerful and technologically advanced Dimension analyze with new standard for excellence in clinical diagnostics. Simply put, t...
Medicine Products: